Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Jackman D, Pao W, Riely GJ, Engelman JA, Kris MG, Jänne PA, Lynch T, Johnson BE, Miller VA
J Clin Oncol. 2010 28 (2): 357-60

PMID: 19949011 · PMCID: PMC3870288 · DOI:10.1200/JCO.2009.24.7049

MeSH Terms (13)

Carcinoma, Non-Small-Cell Lung Disease-Free Survival Drug Resistance, Neoplasm ErbB Receptors Erlotinib Hydrochloride Gefitinib Genes, erbB-1 Guidelines as Topic Humans Lung Neoplasms Mutation Protein Kinase Inhibitors Quinazolines

Connections (1)

This publication is referenced by other Labnodes entities: